Effect of Functional Magnetic Therapy on Constipation Predominant- Irritable Bowel Syndrome (IBS-C)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07256262

Title field or adapter rule

{'original_value': 'Effect of Functional Magnetic Therapy on Constipation Predominant- Irritable Bowel Syndrome (IBS-C)', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:35.161058+00:00

Published At

2025-12-01T00:00:00+00:00

Record Updated At

2025-12-01

Source Retrieved At

2026-10-31T22:18:50.761385+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Irritable Bowel Syndrome"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2025-12-01", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07256262"

protocolSection.identificationModule.officialTitle

"Effect of Functional Magnetic Therapy on Constipation Predominant- Irritable Bowel Syndrome (IBS-C)"

protocolSection.statusModule.overallStatus

"NOT_YET_RECRUITING"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Irritable Bowel Syndrome (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Functional magnetic stimulation (FMS) + Conventional pharmacological therapy'], 'description': "Every patient will receive 20-minute FMS sessions on the TESLA FORMER device. Each treatment session will consist of one cycle (20 minutes each) based on the treatment area's size and the investigator's discretion. Treatment will be administered by a single applicator secured directly over the abdominal muscles. The device's output intensity will be escalated to a tolerable level depending on patient feedback, with average maximum intensities ranging from 98% to 100% across treatment sessions. The treatment will be 20 minutes long, with several steps including different frequency modulations to achieve stimulation of different muscle fibres.", 'name': 'Functional magnetic stimulation (FMS)', 'type': 'DEVICE'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Conventional pharmacological therapy', 'Functional magnetic stimulation (FMS) + Conventional pharmacological therapy'], 'description': 'Every patient in both groups will receive conventional pharmacological therapy for 8 weeks.', 'name': 'Conventional pharmacological therapy', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Conventional pharmacological therapy (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.